A patient with psoriasis has recently developed symptoms indicative of psoriatic arthritis, including joint pain and swelling, and elevated inflammatory markers. Considering the patient's comorbidities of hypertension and type 2 diabetes, what is the primary nursing consideration when initiating a new biologic therapy targeting TNF-alpha?

C) Increase the frequency of blood glucose monitoring

A) Monitor for signs of infection due to immunosuppression

B) Adjust the patient's diet to reduce sodium intake

C) Increase the frequency of blood glucose monitoring

D) Educate the patient about potential gastrointestinal side effects

A patient with psoriatic arthritis is being considered for systemic biologic therapy. As the nurse, which of the following interventions should be prioritized to ensure safe management of this patient's condition?

A) Educate the patient about the signs of infection related to biologic therapy.

B) Recommend increasing the dosage of antihypertensive medication.

C) Encourage the patient to discontinue all current medications before starting the biologic agent.

D) Advise the patient to reduce physical activity to prevent joint stress.

A patient with psoriatic arthritis has recently started treatment with a TNF-alpha inhibitor and reports new skin lesions diagnosed as guttate psoriasis following a streptococcal infection. Which nursing intervention is most appropriate to address both the patient's psoriatic arthritis and the new skin lesions?

A) Educate the patient on the importance of adherence to both systemic and topical treatments.

B) Advise the patient to discontinue the TNF-alpha inhibitor immediately.

C) Suggest the patient increase physical activity to improve joint mobility.

D) Recommend reducing fluid intake to manage the increased blood pressure.

A patient with psoriatic arthritis is being treated with a TNF-alpha inhibitor and reports new skin lesions diagnosed as guttate psoriasis following a recent streptococcal infection. Considering the current clinical presentation, what is the most appropriate nursing intervention?

D) Initiate patient education on the potential need for comprehensive infection control measures and early detection of signs of infection.

A) Educate the patient on the importance of adherence to the biologic therapy despite the emergence of new skin lesions.

B) Monitor the patient's blood pressure closely and adjust the antihypertensive medication independently as needed.

C) Advise the patient to discontinue the biologic therapy immediately until the skin lesions resolve.

D) Initiate patient education on the potential need for comprehensive infection control measures and early detection of signs of infection.

A patient with psoriatic arthritis is experiencing mild elevation in liver enzymes and leukopenia after starting a TNF-alpha inhibitor. Which nursing action is most appropriate to prioritize during the patient's follow-up care?

B) Educate the patient on infection prevention strategies and monitor for signs of infection.

A) Discontinue the TNF-alpha inhibitor immediately and notify the healthcare provider.

B) Educate the patient on infection prevention strategies and monitor for signs of infection.

C) Increase the dosage of the patient's antihypertensive medication to manage elevated blood pressure.

D) Recommend the addition of a hepatoprotective supplement to the patient's regimen.

A patient with psoriatic arthritis is being treated with a TNF-alpha inhibitor and presents with mild elevation in liver enzymes and leukopenia. Which nursing intervention is the most appropriate to prioritize at this time?

A) Educate the patient on the importance of regular follow-up blood tests to monitor liver function and white blood cell count.

B) Advise the patient to discontinue the TNF-alpha inhibitor immediately to prevent further liver damage.

C) Instruct the patient to increase fluid intake to flush out potential toxins affecting the liver.

D) Recommend the patient to begin taking over-the-counter supplements to support liver health.

A patient with psoriatic arthritis and uncontrolled hypertension presents with mild anemia, reporting increased fatigue and occasional dizziness. The healthcare team has adjusted the patient's medication regimen, including the addition of a calcium channel blocker to the existing ACE inhibitor. Which nursing intervention is most appropriate to address the patient's current condition and prevent further complications?

B) Monitor the patient's renal function and electrolyte levels due to the combined use of ACE inhibitors and calcium channel blockers.

A) Educate the patient about the importance of a low-sodium diet to help control blood pressure.

B) Monitor the patient's renal function and electrolyte levels due to the combined use of ACE inhibitors and calcium channel blockers.

C) Recommend the patient increase dietary intake of iron-rich foods to address the anemia.

D) Encourage the patient to rest frequently to manage fatigue and prevent dizziness.

A patient with iron deficiency anemia due to chronic inflammation and hypertension reports occasional dizziness after starting a combination of a calcium channel blocker and an ACE inhibitor. What is the most appropriate nursing action to address the dizziness?

C) Educate the patient to rise slowly from sitting or lying positions.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Advise the patient to lie down immediately when feeling dizzy.

C) Educate the patient to rise slowly from sitting or lying positions.

D) Suggest the patient discontinue the calcium channel blocker immediately.

A patient with a history of psoriasis and psoriatic arthritis is being treated for iron deficiency anemia and hypertension. Despite improvements in some symptoms, the patient reports occasional dizziness. Which nursing intervention is most appropriate to address the patient's current condition?

B) Advise the patient to monitor blood pressure at home and report any significant changes.

A) Encourage the patient to increase dietary sodium to manage dizziness.

B) Advise the patient to monitor blood pressure at home and report any significant changes.

C) Recommend that the patient discontinue the calcium channel blocker until further evaluation.

D) Suggest the patient take iron supplements with meals to reduce gastrointestinal upset.

psorasis - Nursing Case Study

Pathophysiology

• Primary mechanism: Psoriasis is primarily driven by an overactive immune response, where T-cells mistakenly attack healthy skin cells. This triggers rapid proliferation of keratinocytes, leading to the accelerated skin cell cycle and plaque formation.

• Secondary mechanism: The dysregulated immune response involves elevated levels of cytokines such as TNF-alpha, IL-17, and IL-23, which perpetuate inflammation and further stimulate keratinocyte proliferation, contributing to the characteristic thickening and scaling of the skin.

• Key complication: Chronic inflammation can lead to joint involvement, resulting in psoriatic arthritis, characterized by joint pain and stiffness, which significantly impacts a patient's quality of life if not managed appropriately.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Metformin, Lisinopril, Topical corticosteroids

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Worsening skin lesions and joint pain

• Key symptoms: Plaque buildup on elbows and knees, increased redness and itching, mild joint swelling and stiffness

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 88 bpm, Respiratory rate 18 breaths per minute, Temperature 98.6°F

Section 1

New Complications:

As the patient's condition progresses, he begins to develop new complications indicative of psoriatic arthritis. He reports increased joint pain, particularly in his fingers and knees, which now exhibit visible swelling and warmth. The joint stiffness is more pronounced in the morning, lasting for over an hour before easing somewhat with movement. Upon physical examination, the nurse notes dactylitis, or "sausage digits," on his right hand, and tenderness at the insertion points of tendons, suggesting enthesitis. These symptoms are consistent with the progression of psoriatic arthritis, a common complication in individuals with psoriasis, and indicate a need for further evaluation and potentially a change in management strategy.

Laboratory tests reveal elevated inflammatory markers, with C-reactive protein (CRP) levels at 12 mg/L (normal <5 mg/L) and erythrocyte sedimentation rate (ESR) at 40 mm/hr (normal <20 mm/hr). These findings corroborate the clinical signs of systemic inflammation. Additionally, the patient undergoes imaging studies that show erosive changes in the small joints of the hands and new bone formation, characteristic of psoriatic arthritis. Given these results, the healthcare team considers introducing a systemic treatment option, such as a biologic agent targeting TNF-alpha or IL-17, to better control both skin and joint symptoms and prevent further deterioration.

This new development requires careful clinical reasoning to balance the management of his psoriatic arthritis with his existing comorbidities of hypertension and type 2 diabetes. The healthcare team must consider potential interactions with his current medications, particularly the need to monitor blood pressure and glucose levels closely if initiating a systemic biologic therapy. The next steps involve a multidisciplinary approach, including a referral to a rheumatologist for specialized assessment and the potential adjustment of his therapeutic regimen to address the dual challenges of psoriasis and psoriatic arthritis, while ensuring optimal control of his other chronic conditions.

Section 2

As the healthcare team initiates the use of a biologic agent, specifically a TNF-alpha inhibitor, the patient is closely monitored for any changes in his condition and potential side effects. Within weeks of starting the treatment, the patient reports a significant reduction in joint pain and stiffness, particularly noting increased mobility in the mornings. However, he also begins to experience mild fatigue and occasional headaches, which are documented as potential side effects of the biologic therapy. His blood pressure, initially stable, has shown a slight increase with recent readings averaging 145/90 mmHg, prompting the team to review his antihypertensive regimen to ensure adequate control.

In addition to these observations, the patient presents with new skin lesions that differ from his typical psoriatic plaques. These lesions are smaller, more numerous, and appear on his scalp and trunk. A dermatology consult confirms these as guttate psoriasis, a subtype often triggered by infections, such as streptococcal throat infection, which the patient had reported experiencing two weeks prior. This development highlights the importance of evaluating potential infectious triggers and adjusting treatment as necessary to address both skin and systemic symptoms effectively.

The interdisciplinary team discusses the need to refine his management plan, considering the balance between effectively controlling psoriatic arthritis symptoms and managing emerging complications. The patient's current medication regimen is re-evaluated, with adjustments made to his antihypertensive therapy and the introduction of topical treatments for the new psoriatic lesions. His comprehensive care plan now includes regular monitoring for infection signs, emphasizing the importance of early detection and intervention to prevent exacerbation of his condition. The team remains vigilant, ready to modify his treatment strategy as his clinical status evolves, ensuring a holistic approach to his complex health needs.

Section 3

In the weeks following the adjustments to the patient’s treatment plan, he returns for a follow-up visit, during which several new diagnostic tests are conducted to evaluate his overall health status and response to the interventions. Laboratory results reveal a mild elevation in liver enzymes, with alanine aminotransferase (ALT) and aspartate aminotransferase (AST) both slightly above the upper limit of normal, suggesting a potential adverse reaction to the TNF-alpha inhibitor. Given these findings, the healthcare team deliberates on the appropriate course of action, considering the risk of hepatotoxicity associated with biologic therapies. The decision is made to closely monitor the liver function tests over the next few weeks while maintaining the current dosage, as the benefits of reduced joint pain and increased mobility are deemed significant for the patient’s quality of life.

Additionally, a complete blood count shows a mild leukopenia, with the white blood cell count dropping to 3.9 x 10^9/L, raising concerns about the patient’s susceptibility to infections. This finding aligns with the patient's recent history of streptococcal infection and guttate psoriasis development. The interdisciplinary team emphasizes the importance of infection prevention strategies, advising the patient to seek prompt medical attention for any signs of infection, such as fever, sore throat, or increased skin lesions. The primary care provider discusses the potential need for prophylactic antibiotics if the frequency of infections increases, weighing the benefits against the risk of antibiotic resistance.

Throughout these developments, the patient’s blood pressure remains at an elevated level, averaging 150/95 mmHg despite adjustments to his antihypertensive regimen. The team considers initiating a combination therapy to better manage his hypertension, recognizing that effective blood pressure control is critical to preventing cardiovascular complications. As the patient continues his journey, the healthcare team remains proactive in addressing each emerging aspect of his condition, ensuring a comprehensive approach that balances the management of psoriatic arthritis, potential side effects of treatment, and the prevention of new complications.

Section 4

During the next follow-up appointment, the patient reports experiencing increased fatigue and occasional episodes of dizziness, which he had initially attributed to his demanding work schedule. However, upon further assessment, the healthcare team identifies a new complication: anemia. The latest complete blood count reveals a hemoglobin level of 10.5 g/dL and a hematocrit of 32%, indicating mild anemia. This finding prompts the team to delve deeper into potential causes, considering the possibility of medication-related bone marrow suppression, nutritional deficiencies, or chronic disease impact. The team decides to order additional tests, including iron studies, vitamin B12, and folate levels, to determine the underlying cause and guide treatment decisions.

Simultaneously, the patient's blood pressure remains uncontrolled, with readings consistently around 155/98 mmHg, despite recent adjustments in his medication regimen. Recognizing the increased cardiovascular risk associated with both hypertension and psoriatic arthritis, the healthcare team opts to initiate a combination therapy that includes a calcium channel blocker in addition to the existing ACE inhibitor. This decision is made after carefully considering the patient's overall medication burden and potential interactions, with the goal of achieving better blood pressure control and reducing long-term cardiovascular complications.

The interdisciplinary team remains vigilant in monitoring the patient's response to these interventions, scheduling more frequent follow-ups to assess any changes in his symptoms, blood pressure, and laboratory values. They also emphasize the importance of lifestyle modifications, such as a low-sodium diet and regular exercise, as adjunctive measures to improve overall outcomes. As the patient navigates these new challenges, the healthcare team continues to provide comprehensive care, ensuring that each aspect of his health is addressed with the same level of attention and expertise.

Section 5

During the subsequent follow-up visit, the healthcare team reviews the results of the additional tests ordered to investigate the cause of the patient's anemia. The iron studies reveal low serum iron levels at 35 mcg/dL, and the total iron-binding capacity (TIBC) is elevated at 410 mcg/dL, with a transferrin saturation of 8%. Additionally, the patient's ferritin level is low at 10 ng/mL, indicating iron deficiency anemia. Vitamin B12 and folate levels are within normal limits, ruling out other nutritional deficiencies. This new information suggests that the anemia is primarily related to iron deficiency, likely exacerbated by the chronic inflammatory state associated with his psoriasis and psoriatic arthritis. The healthcare team discusses these findings with the patient and decides to initiate oral iron supplementation, along with dietary modifications to increase iron intake.

In parallel, the team evaluates the patient's response to the adjusted hypertension regimen that now includes a calcium channel blocker alongside the ACE inhibitor. On examination, there is a modest improvement in blood pressure readings, with recent measurements averaging 145/92 mmHg. Despite this progress, the values remain above the target range. The interdisciplinary team emphasizes continued adherence to the prescribed medication regimen and reinforces lifestyle changes, particularly focusing on a low-sodium diet and weight management, to further aid in blood pressure control.

As the patient adjusts to these new treatment strategies, he reports a slight improvement in energy levels, although occasional dizziness persists. This prompts the team to consider the possibility of orthostatic hypotension as a side effect of the new antihypertensive combination. They advise the patient on strategies to manage this, such as rising slowly from sitting or lying positions, and schedule another follow-up to reassess his symptoms and overall status. The team remains committed to closely monitoring the patient's response to interventions, ready to make further adjustments as needed, ensuring a comprehensive approach to his evolving health needs.